Current status: 1036 hESC lines, 6413 hiPSC lines, and 155 clinical studies, and 2336 certificates
Monthly statistic from Sep 1, 2024
Posted on September 1, 2024
| total lines | 7449 |
| hESC lines | 1036 |
| hiPSC lines | 6413 |
| derivation countries | 50 |
| projects | 305 |
| providers | 926 |
| clinical studies | 155 |
| subclones | 3027 |
| certificates | 2336 |
| cell line certificates | 2191 |
| project certificates | 145 |